NASDAQ:MDSO - Medidata Solutions Stock Price, Forecast & News

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

Medidata Solutions Inc (NASDAQ:MDSO) released its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The business's revenue for the quarter was up 15.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.43 EPS. View Medidata Solutions' Earnings History.

7 equities research analysts have issued twelve-month price targets for Medidata Solutions' stock. Their forecasts range from $74.93 to $96.00. On average, they anticipate Medidata Solutions' share price to reach $89.09 in the next twelve months. This suggests that the stock has a possible downside of 3.4%. View Analyst Price Targets for Medidata Solutions.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 7 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Media headlines about MDSO stock have trended very positive this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medidata Solutions earned a news impact score of 3.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Medidata Solutions.

Some companies that are related to Medidata Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), Allscripts Healthcare Solutions (MDRX), Vocera Communications (VCRA), HealthStream (HSTM) and Computer Programs & Systems (CPSI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), IBM (IBM), Intel (INTC), Ionis Pharmaceuticals (IONS) and Tesla (TSLA).

Medidata Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Westpac Banking Corp (0.04%). Company insiders that own Medidata Solutions stock include Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

MDSO stock was sold by a variety of institutional investors in the last quarter, including Westpac Banking Corp. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael Pray and Robert Taylor. View Insider Buying and Selling for Medidata Solutions.

One share of MDSO stock can currently be purchased for approximately $92.22.

Medidata Solutions has a market capitalization of $5.76 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

The official website for Medidata Solutions is http://www.mdsol.com/.

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]